Gufic BioSciences Ltd logo

Gufic BioSciences Ltd

NSE: GUFICBIO BSE: 509079

₹473.05

-13.95 (2.86%)

Sun, 22 Nov 2026, 11:15 am

mtf coin illustrationMTF 5xInvest in Gufic BioSciences Ltd with 5x LeverageBuy with MTFpremium button ring illustration
Market Cap (in Cr)4728.82
PE Ratio64.58
Dividend0.02
Health TechnologyHealth Technology
Pharmaceuticals: MajorPharmaceuticals: Major
24.5K24.5K

Gufic BioSciences Share Price Live Chart

1 Day

-13.95 (2.86%)

No Result Found

Summary

  • Market Cap (in Cr)

    4192.81

  • Net Profit (in Cr)

    64.21

  • P/B

    4.14

  • Sector P/E

    40.30

  • P/E

    42.90

  • EV/EBITDA

    20.01

  • Debt/Equity (Industry)

    0.19

  • Interest Cover (Industry)

    10.63

  • ROCE (Industry)

    7.84

  • RONW (Industry)

    6.60

  • ROE

    10.14

  • ROCE

    12

  • Debt/Equity

    0.59

  • EPS (TTM)

    7.99

  • Dividend Yield

    0.02

  • Book Value

    70.77

  • Interest Cover

    3.36

Analysis

all

thumbs up icon

Pros

  • Gufic Biosciences is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Gufic Biosciences is profitable, therefore cash runway is not a concern.
  • Gufic Biosciences is profitable, therefore cash runway is not a concern.
  • Debt is well covered by operating cash flow (24.3%, greater than 20% of total debt).
  • Debt is covered by short term assets, assets are 2.3x debt.
thumbs up icon

Cons

  • Gufic Biosciences is not paying a notable dividend for India, therefore no need to check if the payments are increasing.
  • No need to calculate the sustainability of Gufic Biosciences's dividends as it is not paying a notable one for India.
  • Gufic Biosciences is not paying a notable dividend for India, therefore no need to check if the payments are stable.
  • Gufic Biosciences's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Gufic Biosciences's dividend is below the markets top 25% of dividend payers in India (3.08%).

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersSEPT 2026JUN 2026MAR 2026DEC 2025SEPT 2025
Promoters72.5072.5072.5072.5072.50
FII0.450.460.420.440.34
DII3.383.683.833.743.65
Public23.6723.3623.2423.3223.51
Government00000

Read More

Technical Analysis

RSI

45.10

MACD

4.67

50 DMA

425.50

200 DMA

362.45

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic518.78463.18438.37407.58382.77351.98296.38
Fibonacci463.18441.94428.82407.58386.34373.22351.98
Camarilla428.84423.74418.65407.58408.45403.36398.26

Pivots Level: Classic

R3

+111.20

518.78

R2

+55.60

463.18

R1

+30.78

438.37

407.58
407.58
Pivot Point
LTP: 418.25

S1

-24.82

382.77

S2

-55.60

351.98

S3

-111.20

296.38

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    437.43

  • 20-EMA

    434.90

  • 30-EMA

    431.54

  • 50-EMA

    425.85

  • 100-EMA

    409.52

  • 200-EMA

    386.18

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
14 Nov 2026board-meetingsQuarterly Results
07 Aug 2026agm
29 May 2026dividend₹0.10 Dividend /Share28 Aug 2026
29 May 2026board-meetingsAccounts, Final Dividend
13 Feb 2026board-meetingsQuarterly Results, Nine Months Results
14 Nov 2025board-meetingsQuarterly Results
10 Sept 2025agm
22 Aug 2025dividendFinal Dividend - Rs. - 0.122 Sept 2025
30 May 2025dividend₹0.10 Dividend /Share22 Sept 2025
04 Sept 2024agm

Read More

Peer Comparison

Gufic BioSciences Ltd logo

Gufic BioSciences Ltd

Laurus Labs Ltd logo

Laurus Labs Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Zydus Lifesciences Ltd logo

Zydus Lifesciences Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Read More

Gufic BioSciences Ltd About

Gufic BioSciences engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1984

Headquarters

CEO

Jayesh P Choksi

Employees

Contact

Website icon

Website

http://www.gufic.com

Email icon

Email

corporaterelations@guficbio.com; mgr_legal@guficbi

Phone icon

Phone

91-022-66919187/67261007/66919189

Location icon

Location

Shop-37 1st Flr Kamala Bhavan, Swami Nityanand Road Andheri(E, Mumbai, Maharashtra, 400069

Read More

Gufic BioSciences Ltd Company History

YearHistory
2007
  • Dr. M C Dhapalapur was appointed as Director of the Company.
2008
  • The company set up a manufacturing facility for Oncology Products.
2012
  • The Board of Directors recommended dividend @ 5% per share.
2013
  • The company recommended dividend @ 5% per share.
2014
  • Ms. Hemal Deasi was appointed as an Additional Director.
  • The company recommended a dividend of Re. 0.05 per share on equity share of Rs. 1/- each.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
GRAVITON RESEARCH CAPITAL LLPbulkSell587787329.7230 Nov 2023
GRAVITON RESEARCH CAPITAL LLPbulkBuy587787329.6930 Nov 2023
FINANCIAL INVESTORS TRUST A/C GRANDEUR PEAK GLOBAL OPPORTUNITIES FUNDbulkBuy500000205.8912 Aug 2021
GRAVITON RESEARCH CAPITAL LLPbulkBuy460125190.0612 May 2021
GRAVITON RESEARCH CAPITAL LLPbulkSell460125189.9412 May 2021
GKN SECURITIESbulkBuy48725672.9418 May 2017
SAMBHAV PROPERTIES LLPbulkSell710000060.1418 May 2017
PARTH INFIN BROKERS PVT. LTD.bulkSell136630973.7218 May 2017
GKN SECURITIESbulkBuy48056873.9218 May 2017
PARTH INFIN BROKERS PVT LTDbulkBuy67057276.5418 May 2017

Read More

Gufic BioSciences Ltd News

Gufic Biosciences Q2FY27: PAT up 58% YoY to ₹23.5 crore

Gufic Biosciences posted Q2FY27 net profit of ₹23.5 crore, up 57.7% YoY, on total revenue of ₹288.4 crore. EBITDA margin expanded to 17.23% from 16.45% a year ago.

14 Nov 2026

Companies

Gufic Biosciences adds Reeta Shah as independent director

Gufic Biosciences board approved appointing Dr. Reeta Shah as non-executive independent director for 5 consecutive years from December 01, 2026, subject to shareholder approval. She is not debarred from holding the office of Director by any SEBI order.

14 Nov 2026

companies

Gufic BioSciences gets ITAT order for fresh tax assessment

ITAT Mumbai set aside CIT(A) findings for AY 2023-24, restoring matter to Assessing Officer. No immediate demand arises; liability to be determined after fresh proceedings.

04 Nov 2026

companies

Gufic BioSciences wins ₹4.33 crore tax appeal

Gufic BioSciences received an appellate order allowing its appeal against a ₹4.33 crore income tax demand for AY 2024-25, resulting in the deletion of the liability.

29 Sept 2026

companies

Gufic BioSciences gets CRISIL ESG rating of 62

Gufic BioSciences Ltd received an overall ESG rating of 62 (Strong) from Crisil for FY 2025-26. The rating was assigned independently based on public domain information.

28 Sept 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Gufic BioSciences Ltd?

    As of 22/11/2026 at 4:45 PM, Gufic BioSciences Ltd shares are trading at ₹473.05.

  • 2.What is the market cap. of Gufic BioSciences Ltd?

    As of 22/11/2026, the market capitalization of Gufic BioSciences Ltd is ₹4,728.82 crore.

  • 3.When was Gufic BioSciences Ltd founded?

    Gufic BioSciences Ltd was founded in 1984.

  • 4.What are the P/E and P/B ratios of Gufic BioSciences Ltd?

    As of 22/11/2026, Gufic BioSciences Ltd has a P/E ratio of 64.58 and a P/B ratio of 4.14.

  • 5.How can I buy shares of Gufic BioSciences Ltd?

    You can buy shares of Gufic BioSciences Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Gufic BioSciences Ltd?

    As of September,2026, promoters hold 72.50% in Gufic BioSciences Ltd, while FIIs, DIIs and public shareholders hold 0.45%, 3.38% and 23.67%, respectively.

  • 7.Does Gufic BioSciences Ltd pay dividends?

    Yes, Gufic BioSciences Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹0.10 Dividend /Share per share.

  • 8.What is the dividend yield of Gufic BioSciences Ltd?

    As of 22 November, 2026, the dividend yield of Gufic BioSciences Ltd stands at 0.02%.

  • 9.What are the latest financial results of Gufic BioSciences Ltd?

    For the financial year ended March 2025, Gufic BioSciences Ltd reported revenue of ₹820.00 crore and a net profit of ₹69.65 crore.

  • 10.What is the Stock symbol of Gufic BioSciences Ltd?

    GUFICBIO is the stock symbol of Gufic BioSciences Ltd.

  • 11.Who is the CEO of Gufic BioSciences Ltd?

    The CEO of Gufic BioSciences Ltd is Jayesh P Choksi.

pocketful logo lightpocketful logo dark
PricingBecome a Partner
search icon
/

No results for ''

Popular search

  • popular search iconSuzlon Energy Ltd
  • popular search iconIndian Railway Finance Corporation Ltd
  • popular search iconTata Motors Ltd
  • popular search iconTata Steel Ltd
  • popular search iconRail Vikas Nigam Ltd

Recent search

      Log In
      search icon

      No results for ‘’

        Popular search

        • popular search iconSuzlon Energy Ltd
        • popular search iconIndian Railway Finance Corporation Ltd
        • popular search iconTata Motors Ltd
        • popular search iconTata Steel Ltd
        • popular search iconRail Vikas Nigam Ltd
        • popular search iconReliance Industries Ltd
        pocketful logo lightpocketful logo dark
        • Pricing
        • Become a Partner
        Log In
        • home icon
        • arrow iconstocks
        • arrow icongufic biosciences ltd
        • Overview
        • Analysis
        • Financials
        • Ratios
        • shareholding
        • Technical Analysis
        • Corporate Actions
        • Peer Comparison
        • About
        • Company History
        • Deals
        • News
        • FAQs

        Open Your Free Demat Account Now!

        Step into a world of zero fees and limitless opportunities!

        pocketful logo
        • Quick Links

          • Open Demat Account
          • Pocketful Web
          • Pocketful App
          • Pricing
          • Authorised Person
          • Pocketful Calculators
          • Compliance Links
        • Pages

          • Tools
          • Blogs
          • ETF Screener
          • IPO
          • ETF
          • Bonds
          • Index Heat Map
        • Products

          • Stocks
          • Commodity
          • Subscription
          • Free Stock Screener
          • Pocketful GPT
          • MTF
          • Mutual Funds
        • Company

          • About us
          • Contact us
          • Terms and Conditions
          • Policies & Procedures
          • Privacy Policy
          • Disclosure
          • Careers
        • Socials

          • Facebook iconFacebook
          • Twitter iconTwitter
          • Instagram iconInstagram
          • LinkedIn iconLinkedIn
          • Youtube iconYoutube

        2022-25 Pocketful. All rights reserved, Built with in India

        Version -5.76

        app image 1app image 2

        Stocks:

        AllABCDEFGHIJKLMNOPQRSTUVWXYZ

        Explore

        Calculators
        Popular Calculators
        Group Stocks
        Asset Management Companies
        Popular Stocks
        Indian Indices
        Sector Wise Stocks
        IPO
        Share Market
        Best MF Schemes
        Platforms
        Resources
        Gold Rates in Top Cities
        Silver Rates in Top Cities

        Others:

        NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

        Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800